APA (7th ed.) Citation

R, G., NMSA, A., MA, A., TQ, N., W, C., P, Q., . . . JD, B. (2021). Atypically Modified Carbapenem Antibiotics Display Improved Antimycobacterial Activity in the Absence of β-Lactamase Inhibitors. ACS infectious diseases, 7(8), 2425. https://doi.org/10.1021/acsinfecdis.1c00185

Chicago Style (17th ed.) Citation

R, Gupta, et al. "Atypically Modified Carbapenem Antibiotics Display Improved Antimycobacterial Activity in the Absence of β-Lactamase Inhibitors." ACS Infectious Diseases 7, no. 8 (2021): 2425. https://doi.org/10.1021/acsinfecdis.1c00185.

MLA (9th ed.) Citation

R, Gupta, et al. "Atypically Modified Carbapenem Antibiotics Display Improved Antimycobacterial Activity in the Absence of β-Lactamase Inhibitors." ACS Infectious Diseases, vol. 7, no. 8, 2021, p. 2425, https://doi.org/10.1021/acsinfecdis.1c00185.